Loading, please wait...
Date: Jun 19, 2020 01:30 PM - 02:30 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Aug 14, 2020 11:55 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Registration Closed
Registration Closed
Objectives
- Describe the clinical manifestations of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM5)
- Explain the pharmacological treatment approach for schizophrenia and identify the differences in tolerability of typical and atypical antipsychotic
- Identify the clinical factors and patient preferences that influence the prescribing of different antipsychotic formulations
- Interpret the clinical trial outcomes of studies regarding the use of long acting injectables versus oral antipsychotics in schizophrenia therapy
Speaker(s)/Author(s)
|
Jessica Pinchinat, PharmD, RPh |
Activity Number
0010-0000-20-019-L01-P
Date:
06/19/20
Time:
01:30 PM - 02:30 PM
CE Hours
1.00
Registration Closed